Induction of macrophage colony-stimulating factor receptor (c-fms) expression in vascular medial smooth muscle cells treated with heparin binding epidermal growth factor-like growth factor. 1996

T Inaba, and S Ishibashi, and K Harada, and J Ohsuga, and K Ohashi, and H Yagyu, and Y Yazaki, and S Higashiyama, and S Kawata, and Y Matsuzawa, and N Yamada
Third Department of Internal Medicine, University of Tokyo, Hongo 113, Japan.

Vascular smooth muscle cells migrate, proliferate, and transform to foam cells during the atherosclerotic process. We have reported that smooth muscle cells derived from the intima of atherosclerotic lesions express the proto-oncogene c-fms and a scavenger receptor, which are not normally expressed in normal medial smooth muscle cells. In the present study, we demonstrated that heparin binding epidermal growth factor-like growth factor (HB-EGF) induced the expression of c-fms and the scavenger receptor in normal human medial smooth muscle cells to the level observed in the intima. The expression of c-fms was partially inhibited by a protein kinase C inhibitor, suggesting that HB-EGF induces c-fms via pathways that are both dependent on and independent of protein kinase C. By contrast, most of the scavenger receptor induction by HB-EGF was suppressed by protein kinase C inhibitors. These results indicate that two characteristic genes of monocyte-derived macrophages were induced by HB-EGF via different mechanisms. The alteration of gene expression in response to HB-EGF may play an important role in the phenotypic change of smooth muscle cells to macrophage-like foam cells during the atherosclerotic process.

UI MeSH Term Description Entries
D008565 Membrane Proteins Proteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral proteins. They include most membrane-associated enzymes, antigenic proteins, transport proteins, and drug, hormone, and lectin receptors. Cell Membrane Protein,Cell Membrane Proteins,Cell Surface Protein,Cell Surface Proteins,Integral Membrane Proteins,Membrane-Associated Protein,Surface Protein,Surface Proteins,Integral Membrane Protein,Membrane Protein,Membrane-Associated Proteins,Membrane Associated Protein,Membrane Associated Proteins,Membrane Protein, Cell,Membrane Protein, Integral,Membrane Proteins, Integral,Protein, Cell Membrane,Protein, Cell Surface,Protein, Integral Membrane,Protein, Membrane,Protein, Membrane-Associated,Protein, Surface,Proteins, Cell Membrane,Proteins, Cell Surface,Proteins, Integral Membrane,Proteins, Membrane,Proteins, Membrane-Associated,Proteins, Surface,Surface Protein, Cell
D009131 Muscle, Smooth, Vascular The nonstriated involuntary muscle tissue of blood vessels. Vascular Smooth Muscle,Muscle, Vascular Smooth,Muscles, Vascular Smooth,Smooth Muscle, Vascular,Smooth Muscles, Vascular,Vascular Smooth Muscles
D011971 Receptors, Immunologic Cell surface molecules on cells of the immune system that specifically bind surface molecules or messenger molecules and trigger changes in the behavior of cells. Although these receptors were first identified in the immune system, many have important functions elsewhere. Immunologic Receptors,Immunologic Receptor,Immunological Receptors,Receptor, Immunologic,Receptors, Immunological
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004815 Epidermal Growth Factor A 6-kDa polypeptide growth factor initially discovered in mouse submaxillary glands. Human epidermal growth factor was originally isolated from urine based on its ability to inhibit gastric secretion and called urogastrone. Epidermal growth factor exerts a wide variety of biological effects including the promotion of proliferation and differentiation of mesenchymal and EPITHELIAL CELLS. It is synthesized as a transmembrane protein which can be cleaved to release a soluble active form. EGF,Epidermal Growth Factor-Urogastrone,Urogastrone,Human Urinary Gastric Inhibitor,beta-Urogastrone,Growth Factor, Epidermal,Growth Factor-Urogastrone, Epidermal,beta Urogastrone
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000090063 Proto-Oncogene Mas A protein that is encoded by the MAS1 gene. It is a receptor for ANGIOTENSIN 1-7 and acts as an antagonist of ANGIOTENSIN-2 TYPE 1 RECEPTOR. C-Mas Protein,II-Proto-Oncogene Proteins, Cellular,Mas Protein,Mas1 Protein,Proto-Oncogene Protein Mas,Proto-Oncogene Proteins C-Mas-1,C Mas Protein,C-Mas-1, Proto-Oncogene Proteins,Cellular II-Proto-Oncogene Proteins,II Proto Oncogene Proteins, Cellular,Mas, Proto-Oncogene,Protein Mas, Proto-Oncogene,Protein, C-Mas,Protein, Mas,Protein, Mas1,Proteins, Cellular II-Proto-Oncogene,Proto Oncogene Mas,Proto Oncogene Proteins C Mas 1
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D015153 Blotting, Western Identification of proteins or peptides that have been electrophoretically separated by blot transferring from the electrophoresis gel to strips of nitrocellulose paper, followed by labeling with antibody probes. Immunoblotting, Western,Western Blotting,Western Immunoblotting,Blot, Western,Immunoblot, Western,Western Blot,Western Immunoblot,Blots, Western,Blottings, Western,Immunoblots, Western,Immunoblottings, Western,Western Blots,Western Blottings,Western Immunoblots,Western Immunoblottings

Related Publications

T Inaba, and S Ishibashi, and K Harada, and J Ohsuga, and K Ohashi, and H Yagyu, and Y Yazaki, and S Higashiyama, and S Kawata, and Y Matsuzawa, and N Yamada
April 1999, Sheng li xue bao : [Acta physiologica Sinica],
T Inaba, and S Ishibashi, and K Harada, and J Ohsuga, and K Ohashi, and H Yagyu, and Y Yazaki, and S Higashiyama, and S Kawata, and Y Matsuzawa, and N Yamada
February 2002, Hypertension (Dallas, Tex. : 1979),
T Inaba, and S Ishibashi, and K Harada, and J Ohsuga, and K Ohashi, and H Yagyu, and Y Yazaki, and S Higashiyama, and S Kawata, and Y Matsuzawa, and N Yamada
August 1996, Circulation research,
T Inaba, and S Ishibashi, and K Harada, and J Ohsuga, and K Ohashi, and H Yagyu, and Y Yazaki, and S Higashiyama, and S Kawata, and Y Matsuzawa, and N Yamada
August 1993, The Journal of biological chemistry,
T Inaba, and S Ishibashi, and K Harada, and J Ohsuga, and K Ohashi, and H Yagyu, and Y Yazaki, and S Higashiyama, and S Kawata, and Y Matsuzawa, and N Yamada
July 1997, The Biochemical journal,
T Inaba, and S Ishibashi, and K Harada, and J Ohsuga, and K Ohashi, and H Yagyu, and Y Yazaki, and S Higashiyama, and S Kawata, and Y Matsuzawa, and N Yamada
November 1999, Blood,
T Inaba, and S Ishibashi, and K Harada, and J Ohsuga, and K Ohashi, and H Yagyu, and Y Yazaki, and S Higashiyama, and S Kawata, and Y Matsuzawa, and N Yamada
October 2004, Atherosclerosis,
T Inaba, and S Ishibashi, and K Harada, and J Ohsuga, and K Ohashi, and H Yagyu, and Y Yazaki, and S Higashiyama, and S Kawata, and Y Matsuzawa, and N Yamada
October 1995, Arteriosclerosis, thrombosis, and vascular biology,
T Inaba, and S Ishibashi, and K Harada, and J Ohsuga, and K Ohashi, and H Yagyu, and Y Yazaki, and S Higashiyama, and S Kawata, and Y Matsuzawa, and N Yamada
November 1988, Journal of cellular biochemistry,
T Inaba, and S Ishibashi, and K Harada, and J Ohsuga, and K Ohashi, and H Yagyu, and Y Yazaki, and S Higashiyama, and S Kawata, and Y Matsuzawa, and N Yamada
August 1992, The Journal of biological chemistry,
Copied contents to your clipboard!